CENTOGENE N.V. services

Genetic testing is a type of medical test that identifies changes in genes, inherited from our parents, which we then typically pass on to our children. “Mistakes” in our genes (called “pathogenic variants”) can manifest the disease, and genetic tests may be used to confirm the disease diagnosis.

Whole genome sequencing (WGS) identifies almost all changes in a patient’s DNA by sequencing both the entire protein coding and the non-coding regions of the genome.

Whole Exome Sequencing (WES) is a comprehensive genetic test that identifies changes in a patient`s DNA that are causative or related to their medical concerns. By focusing on the entire protein-coding regions of the genome – the exome – WES offers you the coverage you need to diagnose patients rapidly and reliably.

We work with partners to develop new disease models and new biomarkers of disease. We can also use our disease models to identify new drug targets and screen chemical compounds to identify potential new drug candidates. CENTOGENE provides companies with tools to accelerate drug discovery. From population screening studies that elucidate the prevalence of a rare disease to disease modeling, we are your partner in de-risking drug development for rare diseases.

We provide a broad range of services to successfully operate clinical trials. We leverage our proprietary Bio/Databank, multiomic platform, extensive physician network and our experts to ensure efficient and effective solutions to drive progress in the rare disease space.

If you are struggling to become pregnant then genetic testing can often identify the cause, and help a significant number of couples in their desire to have children.

Want to make sure that your baby is growing and developing normally during pregnancy? CentoNIPT® – Safe and accurate prenatal testing – Offers you information about the health and development of your child from as early as the 10th week of pregnancy.* Non-invasive prenatal testing (NIPT) is a new method of testing for common chromosomal abnormalities that can occur in a developing baby. While rare, these chromosome abnormalities can have profound consequences to the life and health of you and your child and it is important to find out as soon as possible.

The fastest and most comprehensive genetic testing available for newborns, infants and children less than 24 months old in intensive care. CentoICU – Genetic Testing When Every Moment Counts. Up to one-third of all babies and children admitted to the ICU have a genetic disease. For many patients, early identification can make a difference in their immediate and long-term health.

Carrier screening can determine if a healthy person carries a genetic disease, identify people at risk of developing a genetic disease, or help assess the risk of a couple passing a genetic disease onto their children.